The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mukherjee, S., Gangopadhyay, H., & Das, D. K. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0728146 · Cited by 124
RetractedIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Zheng, H., Whitman, S. A., Wu, W., Wondrak, G. T., Wong, P. K., Fang, D., & Zhang, D. D. (2011) · Diabetes · doi:10.2337/db11-0807 · Cited by 507
Antioxidant Functions of Sulforaphane: a Potent Inducer of Phase II Detoxication Enzymes
Fahey, J. W., & Talalay, P. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00082-4 · Cited by 482
Ceriello, A., Ihnat, M. A., & Thorpe, J. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1824 · Cited by 413
Tan, Y., Ichikawa, T., Li, J., Si, Q., Yang, H., Chen, X., Goldblatt, C. S., Meyer, C. J., Li, X., Cai, L., et al. (2011) · Diabetes · doi:10.2337/db10-1164 · Cited by 392
Self-citationPalsamy, P., & Subramanian, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.008 · Cited by 380
Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review
Cai, L., & Kang, Y. J. (2001) · Cardiovascular Toxicology · doi:10.1385/ct:1:3:181 · Cited by 376
Self-citationThe role of oxidative stress and NF‐κB activation in late diabetic complications
Mohamed, A. K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, R., & Nawroth, P. P. (1999) · BioFactors · doi:10.1002/biof.5520100211 · Cited by 339
Protective effect of sulforaphane against oxidative stress: Recent advances
Guerrero-Beltrán, C. E., Calderón-Oliver, M., Pedraza-Chaverri, J., & Chirino, Y. I. (2012) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.11.005 · Cited by 320
Chalmers, J., & Cooper, M. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807625 · Cited by 263
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
He, X., Kan, H., Cai, L., & Ma, Q. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.007 · Cited by 249
Self-citationWang, J., Song, Y., Elsherif, L., Song, Z., Zhou, G., Prabhu, S. D., Saari, J. T., & Cai, L. (2006) · Circulation · doi:10.1161/circulationaha.105.537894 · Cited by 222
Self-citationThe role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation
Sykiotis, G. P., Habeos, I. G., Samuelson, A. V., & Bohmann, D. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834136f2 · Cited by 214
Cai, L., Wang, J., Li, Y., Sun, X., Wang, L., Zhou, Z., & Kang, Y. J. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1829 · Cited by 199
Self-citationYang, Y.-C., Lii, C.-K., Lin, A.-H., Yeh, Y.-W., Yao, H.-T., Li, C.-C., Liu, K.-L., & Chen, H.-W. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.007 · Cited by 188
Oxidative Stress, Diabetes, and Diabetic Complications
Wei, W., Liu, Q., Tan, Y., Liu, L., Li, X., & Cai, L. (2009) · Hemoglobin · doi:10.3109/03630260903212175 · Cited by 177
Self-citationCortese, M. M., Suschek, C. V., Wetzel, W., Kröncke, K.-D., & Kolb-Bachofen, V. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.02.013 · Cited by 167
Wang, Y., Feng, W., Xue, W., Tan, Y., Hein, D. W., Li, X.-K., & Cai, L. (2009) · Diabetes · doi:10.2337/db08-1697 · Cited by 167
Self-citationBasu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., & Kassiri, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00452.2009 · Cited by 161
Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
de Haan, J. B. (2011) · Diabetes · doi:10.2337/db11-1072 · Cited by 157
Zhou, G., Li, X., Hein, D. W., Xiang, X., Marshall, J. P., Prabhu, S. D., & Cai, L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.019 · Cited by 123
Self-citationPiao, C. S., Gao, S., Lee, G., Kim, D. S., Park, B., Chae, S., Chae, H., & Kim, S. H. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.009 · Cited by 121
Modulation of Phase II Enzymes by Sulforaphane: Implications for Its Cardioprotective Potential
Angeloni, C., Leoncini, E., Malaguti, M., Angelini, S., Hrelia, P., & Hrelia, S. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900549c · Cited by 117
Weng, C., Chen, M.-J., Yeh, C., & Yen, G. (2011) · New Biotechnology · doi:10.1016/j.nbt.2011.05.003 · Cited by 106
Tan, Y., Li, X., Prabhu, S. D., Brittian, K. R., Chen, Q., Yin, X., McClain, C. J., Zhou, Z., & Cai, L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.034 · Cited by 105
Self-citationZhang, C., Lu, X., Tan, Y., Li, B., Miao, X., Jin, L., Shi, X., Zhang, X., Miao, L., Li, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049257 · Cited by 104
Self-citationLiu, J., Wu, Q., Lu, Y., & Pi, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.021 · Cited by 90
Cai, L. F. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781389646 · Cited by 73
Self-citationHWANG, Y., Kim, H., Han, E. H., & Jeong, H. G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.04.019 · Cited by 65
Yang, J., Tan, Y., Zhao, F., Ma, Z., Wang, Y., Zheng, S., Epstein, P. N., Yu, J., Yin, X., Zheng, Y., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00629.2010 · Cited by 59
Self-citationEarly Insulin Treatment to Prevent Cardiovascular Disease in Prediabetes and Overt Diabetes
Román, G., & Hâncu, N. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1128144 · Cited by 18
Cited by
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
“Taken together, these data suggest a protective role for Nrf2 in the development and progression of DM and indicate that Nrf2-activating agents may be of value in the treatment of complications caused by the disease [453, 458].”
Tan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 835
Self-citationNrf2 at the heart of oxidative stress and cardiac protection
Chen, Q. M., & Maltagliati, A. J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2017 · Cited by 474
Self-citationAbed, D. A., Goldstein, M., Albanyan, H., Jin, H., & Hu, L. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.008 · Cited by 319
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4826724 · Cited by 301
Metadata
- Authors
- Bai, Y., Cui, W., Xin, Y., Miao, X., Barati, M. T., Zhang, C., Chen, Q., Tan, Y., Cui, T., Zheng, Y., & Cai, L.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 57
- Pages
- 82-95
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2005859751
- Cited by
- 274
- References
- 35
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.